Literature DB >> 16925512

Design and characterization of a functional library for NMR screening against novel protein targets.

Kelly A Mercier1, Katherine Germer, Robert Powers.   

Abstract

In the past few years, NMR has been extensively utilized as a screening tool for drug discovery using various types of compound libraries. The designs of NMR specific chemical libraries that utilize a fragment-based approach based on drug-like characteristics have been previously reported. In this article, a new type of compound library will be described that focuses on aiding in the functional annotation of novel proteins that have been identified from various ongoing genomics efforts. The NMR functional chemical library is comprised of small molecules with known biological activity such as: co-factors, inhibitors, metabolites and substrates. This functional library was developed through an extensive manual effort of mining several databases based on known ligand interactions with protein systems. In order to increase the efficiency of screening the NMR functional library, the compounds are screened as mixtures of 3-4 compounds that avoids the need to deconvolute positive hits by maintaining a unique NMR resonance and function for each compound in the mixture. The functional library has been used in the identification of general biological function of hypothetical proteins identified from the Protein Structure Initiative.

Mesh:

Substances:

Year:  2006        PMID: 16925512     DOI: 10.2174/138620706777935342

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  11 in total

1.  Advances in Nuclear Magnetic Resonance for Drug Discovery.

Authors:  Robert Powers
Journal:  Expert Opin Drug Discov       Date:  2009-10-01       Impact factor: 6.098

2.  FAST-NMR: functional annotation screening technology using NMR spectroscopy.

Authors:  Kelly A Mercier; Michael Baran; Viswanathan Ramanathan; Peter Revesz; Rong Xiao; Gaetano T Montelione; Robert Powers
Journal:  J Am Chem Soc       Date:  2006-11-29       Impact factor: 15.419

Review 3.  The application of FAST-NMR for the identification of novel drug discovery targets.

Authors:  Robert Powers; Kelly A Mercier; Jennifer C Copeland
Journal:  Drug Discov Today       Date:  2008-02       Impact factor: 7.851

Review 4.  Application of NMR and molecular docking in structure-based drug discovery.

Authors:  Jaime L Stark; Robert Powers
Journal:  Top Curr Chem       Date:  2012

Review 5.  Advances in protein NMR provided by the NIGMS Protein Structure Initiative: impact on drug discovery.

Authors:  Gaetano T Montelione; Thomas Szyperski
Journal:  Curr Opin Drug Discov Devel       Date:  2010-05

6.  Correlation between protein function and ligand binding profiles.

Authors:  Matthew D Shortridge; Michael Bokemper; Jennifer C Copeland; Jaime L Stark; Robert Powers
Journal:  J Proteome Res       Date:  2011-03-22       Impact factor: 4.466

7.  Identification of a Ligand-Binding Site on the Staphylococcus aureus DnaG Primase C-Terminal Domain.

Authors:  Jonathan Catazaro; Jessica Periago; Matthew D Shortridge; Bradley Worley; Andrew Kirchner; Robert Powers; Mark A Griep
Journal:  Biochemistry       Date:  2017-02-09       Impact factor: 3.162

8.  Estimating protein-ligand binding affinity using high-throughput screening by NMR.

Authors:  Matthew D Shortridge; David S Hage; Gerard S Harbison; Robert Powers
Journal:  J Comb Chem       Date:  2008-10-03

9.  Structure and function of Pseudomonas aeruginosa protein PA1324 (21-170).

Authors:  Kelly A Mercier; John R Cort; Michael A Kennedy; Erin E Lockert; Shuisong Ni; Matthew D Shortridge; Robert Powers
Journal:  Protein Sci       Date:  2009-03       Impact factor: 6.725

10.  Structural and functional similarity between the bacterial type III secretion system needle protein PrgI and the eukaryotic apoptosis Bcl-2 proteins.

Authors:  Matthew D Shortridge; Robert Powers
Journal:  PLoS One       Date:  2009-10-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.